A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants
Clinical trial NCT04927065 · COMPLETED
Trial details
- NCT number
- NCT04927065
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2023-11-17
- Enrollment
- 5161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.